Search

A study conducted at Henan Agricultural University in China explored the role of lncLLM in lipid metabolism in chicken LMH cells. The research found that lncLLM promotes lipid deposition by facilitating the ubiquitination of MYH9 protein, leading to increased intracellular triglyceride and cholesterol content. This discovery may offer new insights into improving egg-laying performance in hens and treating fatty liver disease in humans. For more information, the full article can be accessed in the International Journal of Molecular Sciences. [Extracted from the article]

University of Minnesota researchers have conducted a study on the relationship between obesity, cardiometabolic complications, and cognitive health. The research suggests that aberrant brain metabolism and cognitive impairment associated with obesity may be linked to changes in tissue glucose and ketone body metabolism. The study explores the therapeutic potential of ketone bodies in treating cardiometabolic diseases and neurodegenerative diseases that lead to cognitive decline. This research provides insights into the associations among cardiometabolic disease, ketone body metabolism, and cognitive health, offering a theoretical framework for promoting positive health outcomes and preserving cognitive function. [Extracted from the article]

Researchers at the University of Hong Kong conducted a study on the effects of intermittent hypoxia (IH) on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice. The study found that IH may lead to liver injury through differential regulation of CD36 expression in these mice. The research was supported by the Sanming Project of Medicine in Shenzhen, China, and was published in the Biomedical Journal. For more information, readers can contact Judith Choi Wo Mak at the University of Hong Kong, Shenzhen Hospital. [Extracted from the article]

Ping An Health recently upgraded its chronic disease management services, expanding to include prevention and management solutions for fatty liver disease, hyperuricemia, and hyperlipidemia. The program also integrates wearable devices and offline medical services, offering customers more comprehensive health management services. Additionally, Ping An Health's digital weight management program showed positive results, with participants achieving an average weight reduction of 1.5kg and a decrease in BMI of 0.6kg/m2. The initiative aims to provide comprehensive health management services for employees nationwide, assisting in weight management and chronic disease prevention. [Extracted from the article]

The article from Blood Weekly discusses a case study on acute fatty liver of pregnancy (AFLP) leading to postpartum liver failure requiring a liver transplant. The research highlights the importance of closely monitoring AFLP postpartum, even if initial symptoms appear to resolve after delivery. The study was conducted at Stony Brook University Hospital in New York and emphasizes the need for continued vigilance in managing AFLP. For more information, readers can access the full article through the provided link. [Extracted from the article]

The University of Austral in Buenos Aires, Argentina, conducted research on the role of Secreted Protein Acidic and Rich In Cysteine (SPARC) in obesity, type 2 diabetes, and non-alcoholic fatty liver disease. The study found that SPARC plays a significant role in adipogenesis, cellular metabolism, extracellular matrix modulation, and glucose and lipid metabolism. This research suggests that SPARC could be a potential target for therapeutic interventions or a biomarker for disease progression in these conditions. The findings were published in the Journal of Physiology and Biochemistry and have been peer-reviewed. [Extracted from the article]

Researchers at Suzhou Ninth People's Hospital conducted a study on lipid metabolism disorders, focusing on the impact of Hepatocyte nuclear factor 1 homeobox A (HNF1A) on type 2 diabetes combined with non-alcoholic fatty liver disease (NAFLD). The study found that knockdown of HNF1A improved glucose and lipid metabolism disorders in mice with high-fat diet and hyperglycemia, as well as modulated the PI3K/AKT/mTOR signaling pathway. The research suggests that targeting HNF1A could be beneficial in ameliorating type 2 diabetes and NAFLD. For more information, the study is published in the Journal of Men's Health. [Extracted from the article]

A study conducted by researchers at Fudan University (Xiamen Branch) in China examined the prognostic value of the fatty liver index (FLI) in predicting mortality. The study, which analyzed data from over 11,000 participants, found that FLI 60 was independently associated with an increased risk of all-cause mortality, as well as mortality from malignant neoplasms, diabetes, and cardiovascular diseases. The research suggests that targeted attention is needed for postmenopausal women, non-overweight individuals, and those without abdominal obesity. [Extracted from the article]

A study conducted at Ahvaz Jundishapur University of Medical Sciences compared liver fibrosis in patients with diabetes and prediabetes. The research found that diabetic patients had a higher severity of liver fibrosis compared to prediabetic patients. Both groups showed a significant relationship between liver fibrosis and HbA1C levels, with prediabetes also being associated with an elevated risk of liver fibrosis. The study did not find a statistically significant relationship between liver fibrosis and age, sex, body mass index, ALT, and ALKP in either group. [Extracted from the article]

The article from Hepatitis Weekly discusses research conducted at the Second Affiliated Hospital of Chongqing Medical University on the mechanisms of Cornus officinalis in treating non-alcoholic steatohepatitis (NASH). The study utilized network pharmacology, molecular docking, and molecular dynamics simulations to identify active ingredients in Cornus officinalis that target NASH-related proteins. The research concluded that Cornus officinalis has multiple active ingredients that bind strongly to NASH targets, highlighting the potential of traditional Chinese medicine in treating NASH. The study was funded by the Natural Science Foundation Project of Chongqing and published in Discover Applied Sciences. [Extracted from the article]

A study conducted at Putian University in Fujian, China, focused on the diagnostic value of liver biopsy in patients with acute and chronic liver diseases, particularly chronic hepatitis B. The research aimed to evaluate the efficacy of antiviral therapy through repeated liver biopsies. The study found a 79.45% concordance rate between clinical and histopathological diagnoses, with liver biopsy proving useful in assessing liver fibrosis before and after antiviral treatment for chronic hepatitis B. The findings suggest that liver biopsy plays a crucial role in diagnosing liver diseases and monitoring treatment effectiveness. [Extracted from the article]

The patent application titled "Sulfonimidamde Compounds And Uses Thereof" by Genentech Inc. discusses the use of sulfonimidamide compounds in treating disorders related to cytokine modulation and NLRP3 inflammasome activation. The NLRP3 inflammasome is implicated in various diseases, including type 2 diabetes, Alzheimer's disease, and atherosclerosis. The application aims to provide compounds and pharmaceutical compositions for inhibiting NLRP3 activation to treat immune, liver, lung, skin, cardiovascular, renal, gastrointestinal, respiratory, endocrine, central nervous system disorders, inflammatory disorders, autoimmune disorders, and cancers. [Extracted from the article]

A recent study conducted at Fuwai Hospital explored the potential causal association between non-alcohol fatty liver disease (NAFLD) and coronary artery calcification (CAC) using genetic analysis. The study found no significant genetic association between NAFLD and CAC, suggesting that previous observational studies linking the two may be influenced by other factors. The research concluded that the association between NAFLD and CAC may be related to metabolic disorders rather than direct hepatic steatosis. For more information, the study titled "The Association between Non-Alcohol Liver Fatty Disease and Coronary Artery Calcification: A Two-Sample Mendelian Randomization Study" can be accessed in the European Journal of Preventive Cardiology. [Extracted from the article]

A study conducted at Nanjing Medical University in Jiangsu, China, compared the clinical characteristics and outcomes of Metabolic dysfunction-associated fatty liver disease (MAFLD) and nonalcoholic fatty liver disease (NAFLD) in a Chinese health examination population. The research found that MAFLD may be better than NAFLD in identifying fatty liver with worse clinical features and risk profiles. The study included 72,392 participants and concluded that MAFLD patients were more likely to be male, overweight, and have higher biochemical indices compared to NAFLD patients. The findings suggest that MAFLD may be a more accurate diagnostic term for identifying high-risk individuals with fatty liver disease. [Extracted from the article]

Researchers at Goethe-University Frankfurt conducted a study on fatty liver disease, focusing on the role of the inhibitor-kappaB kinase epsilon (IKKe) in atherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLD). By employing a mouse model with hepatic PCSK9D377Y overexpression and a high-fat diet, they found that IKKe knockout mice showed reduced atherosclerotic plaques, serum lipid concentrations, and liver steatosis compared to wild-type mice. The study suggests that inhibiting the IKKe pathway could be a novel approach for treating cardiovascular and metabolic diseases. The research was supported by various organizations and published in the International Journal of Molecular Sciences. [Extracted from the article]

The article discusses the harmful effects of chronic inflammation in the liver on brain health, leading to cognitive decline. Researcher Deepa Sathyaseelan from the University of Oklahoma received a grant to study the liver-brain crosstalk and the role of necroptosis in triggering inflammation. The study aims to understand how liver inflammation affects brain function with age and may have implications for liver disease and cognitive impairment in older adults. The findings could potentially lead to new treatments for conditions like fatty liver disease and liver cancer, as well as cognitive dysfunction. [Extracted from the article]

Researchers at Manipal Academy of Higher Education in Karnataka, India, have conducted a study on tissue engineering, focusing on scaffold-mediated liver regeneration. The liver plays a crucial role in maintaining homeostasis, detoxification, and metabolism, but diseases like cirrhosis and hepatitis pose significant global health challenges. The study explores innovative strategies such as 3D bioprinting and microfluidics to create advanced in vitro liver models for drug screening and disease research. Tissue engineering, utilizing polymer-based scaffolds and 3D bioprinting, shows promise in addressing the challenges of liver diseases, including organ shortages for transplantation. [Extracted from the article]

Researchers from the Royal Netherlands Academy of Arts and Sciences have made advancements in studying Non-Alcoholic Fatty Liver Disease (NAFLD) using human fetal hepatocyte organoids. These organoid models help in target discovery and drug screening for steatosis, the first stage of NAFLD. The study identified compounds effective at resolving steatosis and highlighted the importance of FADS2 in hepatic steatosis. This research provides valuable insights into the etiology of steatosis and potential drug targets for NAFLD. [Extracted from the article]

A study conducted in Mexico City examined the incidence of non-alcoholic fatty liver disease (NAFLD) in people living with HIV who were starting antiretroviral therapy. The research found that there was a high incidence of NAFLD in this population, with risk factors including baseline overweight, low HDL-cholesterol, and specific biomarkers at 48 weeks of treatment. The study concluded that these findings highlight the importance of monitoring and managing liver health in individuals with HIV starting antiretroviral therapy. [Extracted from the article]

Researchers at Shanxi University in China have conducted a study on non-alcoholic fatty liver disease (NAFLD), a serious health threat with no effective treatment. Their research focused on the potential benefits of isorhamnetin found in quinoa whole-grain flavonoids in mitigating NAFLD by modulating bile acid metabolism through the regulation of specific genes. The study suggests that isorhamnetin shows promise as a treatment for NAFLD due to its lipid-lowering and hepatoprotective activities. For more information, the full article can be accessed through the publisher MDPI AG. [Extracted from the article]

Researchers at Stanford University have conducted a study on metabolic dysfunction-associated fatty liver disease (MASLD), which is a prevalent chronic liver pathology in western countries. The study aimed to identify causal genes for MASLD using genome-wide association studies and functional genomic frameworks. The research identified VKORC1, TNKS, LYPLAL1, and GPAM as regulators of lipid accumulation in hepatocytes, with VKORC1 being highlighted as a potential MASLD gene. This study provides a new approach to studying MASLD genes and has been peer-reviewed for publication in Hepatology. [Extracted from the article]

Recent studies from Menoufia University have explored the potential of serum bile acids as noninvasive biomarkers for non-alcoholic fatty liver disease (NAFLD). The research found that specific bile acids, such as CA, GCA, TCA, and TCDCA, were strong predictors of disease severity, indicating their potential as biomarkers for NAFLD treatment and prognosis. The study highlighted significant alterations in bile acid profiles associated with NAFLD progression, suggesting the importance of these biomarkers in diagnosing and predicting disease progression. [Extracted from the article]

Research from Universidade de Marilia explores Metabolic-Associated Fatty Liver Disease (MAFLD), emphasizing the role of oxidative stress, inflammation, mitochondrial dysfunctions, and the potential benefits of polyphenols in managing the condition. Lifestyle factors, such as diet and sedentary habits, play a significant role in the development of MAFLD. Polyphenols like anthocyanin, curcumin, and resveratrol show promise in reducing liver damage and improving various health markers associated with MAFLD. The study suggests that polyphenols could be valuable in both preventing and treating MAFLD. [Extracted from the article]

A recent study from the University of Rome La Sapienza highlights the importance of addressing metabolic dysfunction in liver diseases, particularly Metabolic Steatotic Liver Disease (MASLD). The research focuses on the role of hepatokines, specifically fibroblast growth factor 21 (FGF21) and fetuin-A, in regulating metabolic abnormalities associated with MASLD. The study suggests that modulation of these hepatokines by GLP1-Ras may offer therapeutic benefits for managing metabolic and liver diseases. Further research is needed to explore the potential of this pharmacotherapy in addressing the metabolic dysfunction of MASLD. [Extracted from the article]

A recent study conducted at Zhejiang University School of Medicine explored the correlation between Hashimoto's thyroiditis and Metabolic dysfunction-associated fatty liver disease (MAFLD) while screening high-risk groups for liver fibrosis in MAFLD patients. The study found that age, BMI, FBG, and AST are risk factors for high-risk liver fibrosis in MAFLD patients, with specific age and AST levels indicating increased risk. The research highlights the importance of identifying indicators for liver fibrosis in MAFLD patients to improve prevention and treatment strategies. [Extracted from the article]

A recent study conducted among community health workers in a rural area focused on the risk assessment of Metabolic Associated Steatotic Liver Disease (MASLD), commonly known as non-alcoholic fatty liver disease (NAFLD). The study found that physical inactivity was linked to fatty liver alterations and liver fibrosis, along with an elevated waist-hip ratio. The researchers emphasized the importance of lifestyle changes, such as a healthy diet and regular exercise, to prevent and manage fatty liver disease. This study provides valuable insights for healthcare providers to develop personalized interventions and promote healthy lifestyles to reduce the burden of MASLD in the community. [Extracted from the article]

Researchers at Hospital Zambrano Hellion in Mexico conducted a study on the use of Transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis in a private medical setting. The study focused on the indications and outcomes of TIPS procedures, with a high success rate in achieving hemodynamic and technical outcomes. The main indication for TIPS was the secondary prevention of recurrent variceal bleeding, and the study is the first in Mexico to analyze these outcomes in patients undergoing TIPS. [Extracted from the article]